Rankings
▼
Calendar
CAMP
CAMP4 Therapeutics Corporation
$125M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$68M
-16.6% YoY
Gross Profit
$28M
41.0% margin
Operating Income
-$4M
-6.5% margin
Net Income
-$9M
-13.4% margin
EPS (Diluted)
$-0.26
QoQ Revenue Growth
-0.6%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$10M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$392M
Total Liabilities
$316M
Stockholders' Equity
$75M
Cash & Equivalents
$79M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$68M
$82M
-16.6%
Gross Profit
$28M
$35M
-18.9%
Operating Income
-$4M
-$289,000
-1429.1%
Net Income
-$9M
-$9M
-5.2%
Revenue Segments
Product
$39M
57%
Application Subscriptions And Other Services
$29M
43%
Geographic Segments
UNITED STATES
$47M
69%
E M E A
$12M
18%
L A S F
$5M
7%
Asia Pacific
$3M
5%
All Other
$444,000
1%
← FY 2022
All Quarters
Q2 2022 →
CAMP Q1 2022 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena